(I) International Standard Dynamics
The International Pharmaceutical Excipients Council (IPEC) pays close attention to the standards for empty gelatin capsules and vigorously promotes the unification of global pharmaceutical excipient standards. The guidance document it issued provides detailed suggestions on the raw material sources, production processes and quality inspections of empty gelatin capsules, helping companies improve product quality and meet the regulatory needs of various countries. For example, it emphasizes the selection of animal-derived gelatin that meets international standards, strictly traces the animal breeding process, and ensures the safety of raw materials; it recommends the introduction of automated equipment to monitor key parameters such as temperature and humidity in real time to reduce the impact of human factors.
The U.S. Food and Drug Administration (FDA) continues to update regulatory requirements, increase the intensity of random inspections of imported empty gelatin capsules, focus on testing indicators such as heavy metals, microbial limits and disintegration time limits, and take measures such as banning imports and recalls for unqualified products. At the same time, companies are encouraged to use high-resolution mass spectrometry technology to detect impurities and ensure product quality. The EU is also strict in the standards for empty gelatin capsules. The regulations have clear provisions for the physical, chemical and biological properties of capsules, such as strict control of indicators such as size deviation, cross-linking degree, and microbial contamination level, and require companies to mark the ingredients, process, storage conditions and expiration date in detail on product labels for easy supervision.
(II) International market supply situation
As a giant in the global production of pharmaceutical capsules, Capsugel, an American company, occupies an important position in the production of empty gelatin capsules. The company produces a large number of gelatin hollow capsules of various models, including No. 0, for the world every year, and its products are sold well in many countries and regions around the world. It continues to innovate in production technology and adopts advanced automated production lines, which greatly improves production efficiency and product quality stability. For example, by optimizing the design of capsule molds, the capsule molding is more accurate and the size deviation is smaller; using intelligent control systems, the precise delivery of raw materials in the production process and the real-time adjustment of equipment operating parameters can be achieved. At the same time, Capsugel focuses on R&D investment and is committed to developing new gelatin hollow capsule products, such as capsules with special drug release properties to meet the needs of different drugs.
In addition to the United States, India is also an important producer and exporter of gelatin hollow capsules. India has many gelatin hollow capsule manufacturers, and with its relatively low production costs and abundant labor resources, it has a certain price competitive advantage in the international market. The gelatin hollow capsules produced in India are not only supplied to the domestic market, but also exported in large quantities to Europe, Asia and other regions. In the production process, Indian companies gradually focus on quality improvement and actively introduce internationally advanced production technology and quality management systems to improve the competitiveness of their products in the international market. For example, some companies obtain international certifications, such as ISO quality management system certification and GMP certification, to prove that their product quality meets international standards.
(III) International product applications and prospects
In the international pharmaceutical market, No. 0 gelatin empty capsules are widely used in the packaging of various types of medicines. Whether it is prescription drugs or over-the-counter drugs, gelatin empty capsules have become the preferred packaging form for many pharmaceutical companies due to their good drug compatibility and convenient use. For example, in developed countries such as Europe and the United States, many drugs for the treatment of chronic diseases, such as cardiovascular disease drugs and diabetes drugs, are often packaged in No. 0 gelatin empty capsules. In the field of health care products, No. 0 gelatin empty capsules are also widely used to fill various nutritional supplements, vitamins and other products for consumers to take. With the deepening of global aging and the increasing attention of people to health, the demand for medicines and health care products continues to grow, which will bring a broad market space for No. 0 gelatin empty capsules. At the same time, with the continuous advancement of science and technology, the research and development of new drug dosage forms has put forward higher requirements on the performance of capsules, prompting enterprises to increase R&D investment, develop gelatin hollow capsule products with better stability and higher bioavailability, and further expand the application areas of No. 0 gelatin hollow capsules in the international market. For example, the development of targeted gelatin hollow capsules that can release drugs at specific sites can improve the therapeutic effect of drugs and reduce drug side effects.